Stockreport

Seneca Biopharma Announces Closing of Exercise of Warrants for $7.55 Million Gross Proceeds

Seneca Biopharma, Inc.  (SNCA) 
PDF GERMANTOWN, Md., Jan. 22, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a clinical-stage biopharmaceutical company developing novel treatments for various [Read more]